Ayako Arai1,2, Ichiro Yonese2, Hiroshi Takase3, Mayumi Yoshimori1, Tohru Miki4, Manabu Mochizuki3, Osamu Miura2 (1.Laboratory Molecular Genetics of Hematology, TMDU, Tokyo, Japan, 2.Hematology, TMDU, Tokyo, Japan, 3.Ophthalmology,TMDU, Tokyo, Japan, 4.Internal medicine, Flowers & Forest Tokyo Hospital, Tokyo, Japan)
Session information
Oral Session
Oral Session 1-7C Maliginant lymphoma: Basic (3)
Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.7 (Osaka International Convention Center, 10F 1001)
Chair: Takashi Ishida (Iwate Medical University, Japan)
Ryota Shirai1,2, Yoko Shioda3, Tomoo Osumi1,3, Shin-Ichi Tsujimoto1,2, Masanori Yoshida1,2, Toru Uchiyama4, Daisuke Tomizawa3, Chikako Kiyotani3, Keita Terashima3, Kimikazu Matsumoto3, Nobutaka Kiyokawa1, Takako Yoshioka5, Motohiro Kato1,3 (1.Pediatric Hematology and Oncology Research, NCCHD, Tokyo, Japan, 2.Pediatrics, Yokohama City University Graduate School of Medicine, Kanagawa Japan, 3.Children Cancer Center, NCCHD, Tokyo, Japan, 4.Human Genetics, NCCHD, Tokyo, Japan, 5.Pathology, NCCHD, Tokyo, Japan)
Kensuke Sasaki1, Kohta Miyawaki1, Takeshi Sugio1, Koichi Ohshima2, Takahiro Maeda1, Koji Kato1, Koichi Akashi1 (1.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 2.Department of Pathology, Kurume University School of Medicine, Kurume, Japan)
Kazuho Morichika1, Kennosuke Karube2, Risa Watanabe3, Mamoru Kawaki3, Sakiko Kitamura1, Sachie Uchibori1, Shouhei Tomori1, Taeko Hanashiro1, Natsuki Shimabukuro1, Iori Tedokon1, Keita Tamaki1, Yukiko Nishi1, Sawako Nakachi1, Satoko Morishima1, Junnosuke Uchihara4, Takeaki Tomoyose5, Kazuiku Ohshiro5, Iwao Nakazato6, Atsushi Yamanoha7, Takashi Miyagi7, Tetsuro Nakazato8, Masaki Hayashi9, Taishi Takahara10, Akira Sato10, Satoko Shimada11, Kazuyuki Shimada12, Toyonori Tsuzuki10, Shigeo Nakamura11, Takuya Fukushima13, Hiroaki Masuzaki1 (1.Second Department of Internal Medicine, Ryukyu Univ., Okinawa, Japan, 2.Department of Cell Biology and Pathology, Ryukyu Univ., Okinawa, Japan, 3.Faculty of Medicine, Ryukyu Univ., Okinwa, Japan, 4.Department of Hematology, Naha-City Hospital, Naha, Okinawa, Japan, 5.Department of Hematology, Okinawa Prefectural Nambu Medical Center, Okinawa, Japan, 6.Department of Pathology, Okinawa Prefectural Nambu Medical Center, Okinawa, Japan, 7.Department of Hematology, Heartlife Hospital, Okinawa, Japan, 8.Department of Hematology, Okinawa Red Cross Hospital, Okinawa, Japan, 9.Department of Hematology, Nakagami Hospital, Okinawa, Japan, 10.Department of Surgical Pathology, Aichi Medical University Hospital, Aichi, Japan, 11.Department of Pathology and Clinical Laboratories, Nagoya Univ., Aichi, Japan, 12.Department of Hematology and Oncology, Nagoya Univ., Aichi, Japan, 13.Laboratory of Hematoimmunology, Health Sciences, Ryukyu Univ., Okinawa, Japan)
Yasuhiro Nagate1, Sachiko Ezoe1, Jiro Fujita1, Takafumi Yokota1, Michiko Ichii1, Akira Tanimura1, Yuri Hamanaka1, Yukiko Doi1, Tomoaki Ueda1, Jun Toda1, Hirohiko Shibayama1, Kenji Oritani1,2, Yuzuru Kanakura1 (1.Dept. Of Hematol. and Oncol., Osaka Univ., Osaka, Japan, 2.Dept. Of Hematol., IUHW., Tochigi, Japan)
Shunsuke Kunou1, Kazuyuki Shimada1, Tomoya Hikita2, Tomohiro Aoki1,3, Akihiko Sakamoto1,4, Noritoshi Kato5, Fumihiko Hayakawa1, Chitose Oneyama2, Hitoshi Kiyoi1 (1.Department of Hematology and Oncology, Nagoya University, Nagoya, Japan, 2.Aichi Cancer Center Research Institute, Nagoya, Japan, 3.The BC Cancer Agency, Canada, 4.National Center for Geriatrics and Gerontology, Japan, 5.Department of Nephrology, Nagoya University, Nagoya, Japan)